Salt Lake City, UT, United States of America

Geoff Herpin


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Geoff Herpin: Innovator in Anti-Viral Therapeutics

Introduction

Geoff Herpin is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of anti-viral therapeutics through his innovative research and patent work. His expertise lies in developing methods that target viral genomes to combat various diseases.

Latest Patents

Geoff Herpin holds a patent for "Oligonucleotide complexes for use as anti-viral therapeutics." This patent outlines methods that are useful for treating a wide variety of diseases. In particular, the methods provide for the targeting of a transcription-altering agent to a specific target site of a viral genome in order to inactivate the virus. Additionally, the methods include a triplex-forming oligonucleotide capable of interacting with a target site in a viral genome to alter transcription. These innovative methods may be employed against viral pathogens or agents of bioterrorism. He has 1 patent to his name.

Career Highlights

Throughout his career, Geoff has worked with esteemed institutions such as the University of Utah Research Foundation and Yale University. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Geoff has collaborated with notable individuals in his field, including John D Kriesel and Brandt B Jones. These partnerships have further enriched his research and innovation efforts.

Conclusion

Geoff Herpin is a distinguished inventor whose work in anti-viral therapeutics has the potential to make a significant impact on public health. His innovative methods and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…